Beranda › Kanker Rahim › Pennsylvania
Uji klinis Kanker Rahim di Pennsylvania
7 studi untuk Kanker Rahim mencari peserta di lokasi di Pennsylvania.
Kota di Pennsylvania
Teks studi resmi (Bahasa Inggris)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- UPMC Vision Institute, Monroeville
- University Ear, Nose, & Throat Eye & Ear Institute, Pittsburgh
- UPMC Magee-Womens Hospital, Pittsburgh
- dan 3 lainnya
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT06952660PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Lancaster General Health - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 17 Sep 2026 · NCT05758688DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Philadelphia
- Research Site, Pittsburgh
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Bethlehem
- Research Site, Hershey
- Research Site, Lancaster
- dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797[18F]FES PET/.CT in Uterine Cancer
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 5 Jun 2026 · NCT05916196Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.